nContact EPi-Sense Cardiac Ablation Device Embeds Sensors, Clears FDA
nContact of Morrisville, NC received FDA go-ahead to market its new EPi-Sense Guided Coagulation Device for treatment of atrial fibrillation and atrial flutter. The device contains special sensors along the ablation section, which assist physicia...
Source: Medgadget - Category: Technology Consultants Authors: Gene Ostrovsky Tags: Cardiac Surgery Vascular Surgery Source Type: blogs
More News: Arrhythmia | Atrial Fibrillation | Cardiac Arrhythmia | Cardiology | Genetics | Heart | Technology Consultants